Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

The case stems from a Cronobacter bacterial contamination at one of Abbott Laboratories' Michigan plants.

Tributary Capital Management released its second-quarter 2026 investor letter for “Multi Cap Core Equity Strategy”. You can download a copy of the letter here. The Tributary Multi Cap Core’s equity ...

Abbott Laboratories has agreed to pay $385 million to resolve a federal investigation and lawsuit, as well as lawsuits filed ...

MarketBeat reported that Abbott's second-quarter results released on July 16, 2026, included quarterly EPS of USD 1.31, which ...

Focus Wealth Management released its Q2 2026 investor letter. You can download a copy of the letter here. The fund highlighted a period of strong equity market gains as the S&P 500 surged ~17% ...

These two high-quality dividend payers have had very different fortunes recently.

Analysts keep raising their price targets on this 54-year dividend raiser. Here are the reasons behind the newfound confidence.

Abbott Laboratories receives a Hold rating, as its current valuation reflects much of its business quality and future growth ...

Abbott Laboratories (NYSE:ABT) is preparing to release its quarterly earnings on Thursday, 2025-07-17. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...

Abbott Laboratories ( ABT) snapped six consecutive sessions of losses as the stock gained 1.21% to close at $103.18 on Monday ...

Abbott Laboratories stock was trading at USD 103.53 on the NYSE on September 23, 2026 at 3:59 p.m. ET, down 0.20 percent. The ...